Modalis Therapeutics (4883.TSE) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-9
-6
-4
-1

Details

Expected EPS
N/A
Actual EPS
-5
Surprise EPS
-5
Surprise Percent
+∞%

Description

Modalis Therapeutics (4883.TSE) has reported earnings of -5 per share for Q3 2025.

0 Comments

Share your thoughts